Sale!

Influenza Group A and B RNA Detection Qualitative Test

1,020 د.إ

-15%

The “Influenza Group A and B RNA Detection Qualitative Test” is a diagnostic procedure designed to identify the presence of influenza viruses Group A and B through the analysis of RNA. This test is pivotal in distinguishing between these two major groups of the influenza virus, which are responsible for seasonal flu epidemics. Utilizing advanced molecular techniques, this qualitative test detects the genetic material (RNA) of the viruses, providing a reliable indication of an infection.

Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test offers a quick and accurate method to diagnose influenza, aiding in the timely treatment and management of the condition. The cost of the test is set at 1020 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. Given the importance of early detection in mitigating the spread of influenza and ensuring effective patient care, this test represents a crucial tool in the healthcare arsenal against viral outbreaks.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Influenza Group A and B RNA Detection Qualitative Test

Cost: AED 1020.0

Symptoms and Diagnosis

The Influenza Group A and B RNA Detection Qualitative Test is a diagnostic tool used to detect the presence of influenza viruses in respiratory samples. It specifically targets the RNA of Influenza A and B viruses. The test is performed using a method called Real Time PCR, which is a molecular technique. It involves the extraction of viral RNA from respiratory samples such as deep nostrils (nasal swab), nasopharynx (nasopharyngeal swab), nasopharyngeal aspirate, throat, or bronchial aspirate. The test is conducted in the Genetics department by a physician.

Test Details

The Influenza Group A and B RNA Detection Qualitative Test is performed using a molecular technique called reverse transcription-polymerase chain reaction (RT-PCR). The process includes the extraction of viral RNA from the respiratory sample, followed by reverse transcription to convert the RNA into complementary DNA (cDNA). The cDNA is then amplified using PCR, allowing for the detection of specific influenza RNA sequences. The test is of viral type and provides a qualitative result, indicating whether the sample is positive or negative for the presence of Influenza A or B viruses. However, it does not provide information on the viral load or the specific subtype of the virus.

Report Delivery

The report for the Influenza Group A and B RNA Detection Qualitative Test is delivered within the 3rd working day via email (36 hours) and can also be obtained over the phone (24 hours).

Pre Test Information

Prior to taking the test, it is necessary to sign a consent document and bring any relevant clinical history of the patient for Influenza Group A and B RNA Detection Qualitative Test.

Benefits

  • Quickly diagnose influenza infections
  • Allows for appropriate patient management and treatment decisions
  • Highly sensitive and specific
  • Reliable results within a short period of time

Conclusion

The Influenza Group A and B RNA Detection Qualitative Test is an effective diagnostic tool used to detect the presence of Influenza A and B viruses in respiratory samples. It is performed using Real Time PCR and provides reliable results within a short period of time. This test is commonly used in clinical settings to quickly diagnose influenza infections, allowing for appropriate patient management and treatment decisions.

Test Name Influenza Group A and B RNA Detection Qualitative Test
Components
Price 1020.0 AED
Sample Condition Deep nostrils (nasal swab), nasopharynx (nasopharyngeal swab), nasopharyngeal aspirate, throat or bronchial aspirate.
Report Delivery 3rd Working Day Email:-36 hours.On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forInfluenza Group A & B (RNA Detection) QualitativeTest
Test Details

The Influenza Group A & B (RNA Detection) Qualitative Test is a diagnostic tool used to detect the presence of influenza viruses in respiratory samples. This test specifically targets the RNA of Influenza A and B viruses.

The test is performed using a molecular technique called reverse transcription-polymerase chain reaction (RT-PCR). It involves the extraction of viral RNA from the respiratory sample, followed by reverse transcription to convert the RNA into complementary DNA (cDNA). The cDNA is then amplified using PCR, which allows for the detection of specific influenza RNA sequences.

The qualitative nature of the test means that it can determine whether the sample is positive or negative for the presence of Influenza A or B viruses. However, it does not provide information on the viral load or the specific subtype of the virus.

This test is commonly used in clinical settings to quickly diagnose influenza infections, allowing for appropriate patient management and treatment decisions. It is highly sensitive and specific, providing reliable results within a short period of time.